CAPTRUST Financial Advisors’s Biote Corp. Warrant BTMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,156
Closed -$4.29K 2618
2023
Q1
$4.29K Buy
+10,156
New +$3.68K ﹤0.01% 2283
2022
Q4
Sell
-17,165
Closed -$6K 2239
2022
Q3
$6K Hold
17,165
﹤0.01% 2038
2022
Q2
$7K Sell
17,165
-475
-3% -$256 ﹤0.01% 3956
2022
Q1
$10K Hold
17,640
﹤0.01% 3828
2021
Q4
$13K Hold
17,640
﹤0.01% 3583
2021
Q3
$14K Hold
17,640
﹤0.01% 3419
2021
Q2
$17K Buy
+17,640
New +$15.3K ﹤0.01% 3236

Other funds holding BTMDW

CAPTRUST Financial Advisors's BTMDW Position: Q2 2023 in Review

CAPTRUST Financial Advisors sold out of Biote Corp. Warrant (BTMDW) in Q2 2023, closing a stake of 10,156 shares — an estimated $4.29K sold.

CAPTRUST Financial Advisors first reported a position in BTMDW in Q2 2021 and held it in 7 quarters. The position peaked at $17K in Q2 2021. 2 funds tracked by Wall St. Rank hold BTMDW as of Q2 2023.

  • CAPTRUST Financial Advisors reported no remaining Biote Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,156 Biote Corp. Warrant shares in Q2 2023, an estimated $4.29K.
  • CAPTRUST Financial Advisors first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Biote Corp. Warrant position peaked at $17K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.